Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension

Arthritis and Rheumatism

Volumn 54, Issue 12, 2006, Pages 3954-3961

  Schachna, Lionel ^a   Medsger Jr , Thomas A ^b   Dauber, James H ^b   Wigley, Fredrick M ^a   Braunstein, Neil A ^b   White, Barbara ^c,d   Steen, Virginia D ^b   Conte, John V ^a   Yang, Stephen C ^a   McCurry, Kenneth R ^b   Borja, Marvin C ^a   Plaskon, David E ^b   Orens, Jonathan B ^a   Gelber, Allan C ^a,e  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

^d MEDIMMUNE   (United States)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOIMMUNE DISEASE; COMPARATIVE STUDY; DISEASE SEVERITY; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; HUMAN; LUNG INSUFFICIENCY; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RECIPIENT; RHEUMATIC DISEASE; RISK ASSESSMENT; SCLERODERMA; SURVIVAL RATE; SYSTEMIC DISEASE; SYSTEMIC SCLEROSIS; TREATMENT INDICATION; UNIVERSITY HOSPITAL;

ADULT; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; HYPERTENSION, PULMONARY; LUNG TRANSPLANTATION; MALE; MARYLAND; MIDDLE AGED; PENNSYLVANIA; PULMONARY ARTERY; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; SCLERODERMA, SYSTEMIC; SURVIVAL RATE;

EID: 33845660778     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.22264     Document Type: Article

References (34)

1. Silver RM, Medsger TA Jr, Boster MB. Systemic sclerosis and scleroderma variants: clinical aspects. In: Koopman WJ and Moreland LW, editors. Arthritis and allied conditions. 15th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p. 1633-80.
2. Medsger TA Jr, Masi AT, Rodnan GP, Benedek TG, Robinson H. Survival with systemic sclerosis (scleroderma): a life-table analysis of clinical and demographic factors in 309 patients. Ann Intern Med 1971;75:369-76.
3. Steen VD, Costantino JP, Shapiro AP, Medsger TA Jr. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme inhibitors. Ann Intern Med 1990; 113:352-7.
4. Lee P, Langevitz P, Alderdice CA, Aubrey M, Baer PA, Baron M, et al. Mortality in systemic sclerosis (scleroderma). Q J Med 1992;82:139-48.
5. Black CM, Du Bois RM. Organ involvement: pulmonary. In: Clements P, Furst DE, editors. Systemic sclerosis. Baltimore: Williams & Wilkins; 1996. p. 299-331.
6. White B, Moore WC, Wigley FM, Xiao HQ, Wise RA. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000;132:947-54.
7. Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized, controlled trial. Ann Intern Med 2000;132:425-34.
8. Rubin LJ, Badesch DB, Barst RJ, Galie N, Black CM, Keogh A, et al. Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 2002;346:896-903.
9. Trulock EP, Edwards LB, Taylor DO, Boucek MM, Mohacsi PJ, Keck BM, et al, for the Registry of the International Society for Heart and Lung Transplantation. Twentieth official adult lung and heart-lung transplant report: 2003. J Heart Lung Transplant 2003;22:625-35.
10. Levine SM, Anzueto A, Peters JI, Calhoon JH, Jenkinson SG, Bryan CL. Single lung transplantation in patients with systemic disease. Chest 1994;105:837-41.
11. Zander DS, Baz MA, Visner GA, Staples ED, Donnelly WH, Faro A, et al. Analysis of early deaths after isolated lung transplantation. Chest 2001;120:225-32.
12. Pigula FA, Griffith BP, Zenati MA, Dauber JH, Yousem SA, Keenan RJ. Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg 1997;64:1630-4.
13. Rosas V, Conte JV, Yang SC, Gaine SP, Borja M, Wigley FM, et al. Lung transplantation and systemic sclerosis. Ann Transplant 2000;5:38-43.
14. Kubo M, Vensak J, Dauber J, Keenan R, Griffith B, McCurry K. Lung transplantation in patients with scleroderma. J Heart Lung Transplant 2001;20:174-5.
15. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
16. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
17. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guideline. Chest 2004; 126(Suppl):1-92S.
18. Gault MH, Longerich LL, Harnett JD, Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992;62:249-56.
19. Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR, for the International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, and the European Respiratory Society. International guidelines for the selection of lung transplant candidates. Transplantation 1998;66:951-6.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
21. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972;135:185-206.
22. Cox DR. Regression models and life tables. J R Stat Soc (B) 1972;34:187-220.
23. Kanasky WF Jr, Anton SD, Rodrigue JR, Perri MG, Szwed T, Baz MA. Impact of body weight on long-term survival after lung transplantation. Chest 2002;121:401-6.
24. Ettinger NA, Bailey TC, Trulock EP, Storch GA, Anderson D, Raab S, et al, for the Washington University Lung Transplant Group. Cytomegalovirus infection and pneumonitis: impact after isolated lung transplantation. Am Rev Respir Dis 1993;147: 1017-23.
25. Christie JD, Bavaria JE, Palevsky HI, Litzky L, Blumenthal NP, Kaiser LR, et al. Primary graft failure following lung transplantation. Chest 1998;114:51-60.
26. Richardson JA. Hemodialysis and kidney transplantation for renal failure from scleroderma. Arthritis Rheum 1973;16:265-71.
27. Keane WF, Danielson B, Raij L. Successful renal transplantation in progressive systemic sclerosis. Ann Intern Med 1976;85: 199-202.
28. McKinney TD, McAllister CJ, Stone WJ, Johnson HK, Ginn HE. Hemodialysis and renal transplantation in progressive systemic sclerosis: report of 2 cases. Clin Nephrol 1979;12:178-85.
29. LeRoy EC, Fleischmann RM. The management of renal scleroderma: experience with dialysis, nephrectomy and transplantation. Am J Med 1978;64:974-8.
30. Chang YJ, Spiera H. Renal transplantation in scleroderma. Medicine (Baltimore) 1999;78:382-5.
31. Woodhall PB, McCoy RC, Gunnells JC, Seigler HF. Apparent recurrence of progressive systemic sclerosis in a renal allograft. JAMA 1976;236:1032-4.
32. Caplin NJ, Dikman S, Winston J, Spiera H, Uribarri J. Recurrence of scleroderma in a renal allograft from an identical twin sister. Am J Kidney Dis 1999;33:e7.
33. Grossman RF, Frost A, Zamel N, Patterson GA, Cooper JD, Myron PR, et al, for the Toronto Lung Transplant Group. Results of single-lung transplantation for bilateral pulmonary fibrosis. N Engl J Med 1990;322:727-33.
34. Trulock EP, Cooper JD, Kaiser LR, Pasque MK, Ettinger NA, Dresler CM, for the Washington University Lung Transplantation Group. The Washington University-Barnes Hospital experience with lung transplantation. JAMA 1991;266:1943-6.